[go: up one dir, main page]

Nelson, 2020 - Google Patents

Engineering Split-Luciferase Assay Systems for Detection of Protein Solubility

Nelson, 2020

Document ID
16937370209178458253
Author
Nelson T
Publication year

External Links

Snippet

Neurodegenerative diseases are a significant public health epidemic. Often these diseases are associated with protein misfolding that results in the formation of insoluble protein fibrils, known as amyloids. As such, these fibrils have been a major focus of research and a target …
Continue reading at search.proquest.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)

Similar Documents

Publication Publication Date Title
Azad et al. Split-luciferase complementary assay: applications, recent developments, and future perspectives
Kopp et al. In vitro FRET analysis of IRE1 and BiP association and dissociation upon endoplasmic reticulum stress
Martin et al. Mammalian cell–based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity
Alford et al. A fluorogenic red fluorescent protein heterodimer
Aper et al. Dual readout BRET/FRET sensors for measuring intracellular zinc
CA2514843A1 (en) Protein fragment complementation assays for high-throughput and high-content screening
CN107074926B (en) Biosensor for monitoring G protein activation based on G beta gamma interaction protein
Yudenko et al. Rational design of a split flavin-based fluorescent reporter
Pandey et al. Combining random gene fission and rational gene fusion to discover near-infrared fluorescent protein fragments that report on protein–protein interactions
Okada et al. Circular permutation of ligand‐binding module improves dynamic range of genetically encoded FRET‐based nanosensor
Kashiwagi et al. Folding latency of fluorescent proteins affects the mitochondrial localization of fusion proteins
Niu et al. Novel fluorescence-based biosensors incorporating unnatural amino acids
Ohmuro‐Matsuyama et al. Improving bioluminescence of a minimal luciferase by adding a charged oligopeptide: picALuc2. 0
De et al. Engineering aspects of bioluminescence resonance energy transfer systems
Ohmuro-Matsuyama et al. Improved Protein–Protein Interaction Assay FlimPIA by the Entrapment of Luciferase Conformation
US20210285031A1 (en) Fret based protein biosensor for detection of cyclic dinucleotides
Nelson Engineering Split-Luciferase Assay Systems for Detection of Protein Solubility
Nguyen et al. Engineering an efficient and bright split Corynactis californica green fluorescent protein
US20250012785A1 (en) Systems and methods for detection and quantification of double-stranded rna
US20090142820A1 (en) Directed evolution methods for improving polypeptide folding, solubility and stability
Nelson et al. A Luminescence-Based System for Identification of Genetically Encodable Inhibitors of Protein Aggregation
Verhoef et al. Visualization of protein interactions in living cells using bimolecular luminescence complementation (BiLC)
JP7582964B2 (en) Split photoactive yellow protein complementation system and uses thereof
Zhu et al. Creating a thermostable β-glucuronidase switch for homogeneous immunoassay by disruption of conserved salt bridges at diagonal interfaces
Keskitalo et al. The non-catalytic ε DNA polymerase subunit is an NPF motif recognition protein